Yayın:
Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults

dc.contributor.authorKomurcu-Bayrak, E.
dc.contributor.authorErginel-Unaltuna, N.
dc.contributor.authorOnat, A.
dc.contributor.authorOzsait, B.
dc.contributor.authorEklund, C.
dc.contributor.authorHurme, M.
dc.contributor.authorMononen, N.
dc.contributor.authorLaaksonen, R.
dc.contributor.authorHergenc, G.
dc.contributor.authorLehtimaki, T.
dc.date.accessioned2026-06-27T13:09:31Z
dc.date.issued2009
dc.description.abstractObjective: Serum C-reactive protein (CRP) is an independent risk factor for cardiovascular disease and metabolic syndrome (MetS). The aim of this study was to analyze the CRP gene allelic variations in the Turkish adult risk factor (TARF) study and relate them with serum CRP levels as well as MetS and its components. Methods: We analyzed CRP gene polymorphisms (-286C>T>A [rs3091244], + 1444C>T [rs1130864], + 1059G>C [rs1800947], and +1846G>A [rs1205]) as well as their haplotypes, in addition to measuring CRP levels (n = 1138) and collecting risk factor data from 1987 adults (mean age 54.3 +/- 11.9 years, 51.3% women) participating in the TARF Study. MetS was defined by using the criteria of the National Cholesterol Education Program modified for pre-diabetes and in men for abdominal obesity. Results: After adjustment for the major cardiovascular risk factors, four CRP SNPs (-286C>T>A, +1059G>C, +1444C>T, and +1846G>A) were significantly associated with serum CRP levels in women (p T>A and +1444C>T polymorphisms were associated with CRP levels in men (p < 0.05). The haplotype analyses revealed four common CRP haplotypes. The haplotype 1 (CGCA) in women and the haplotype 3 (TGTG) in men were associated with serum CRP levels and hypertension (p < 0.05). However, no haplotype association was observed for MetS or its components. Conclusion: CRP gene allelic variation is associated with serum CRP levels as well as hypertension in Turkish adults. (C) 2009 Elsevier Ireland Ltd. All rights reserved.en
dc.description.sponsorshipEmil Aaltonen Foundation
dc.description.sponsorshipTampere University Hospital Medical Foundation (Finland)
dc.description.sponsorshipScientific and Technological Research Council of Turkey [SBAG-3091]
dc.description.sponsorshipTurkish Society of Cardiology
dc.description.sponsorshipAstraZeneca
dc.description.sponsorshipPfizer
dc.description.sponsorshipSanofi-Aventis (Istanbul)
dc.description.urihttps://doi.org/10.1016/j.atherosclerosis.2009.03.030
dc.identifier.doi10.1016/j.atherosclerosis.2009.03.030
dc.identifier.eissn1879-1484
dc.identifier.endpage479
dc.identifier.issn0021-9150
dc.identifier.issue2
dc.identifier.pubmed19410251
dc.identifier.startpage474
dc.identifier.urihttps://hdl.handle.net/20.500.14981/50530
dc.identifier.volume206
dc.identifier.wos000271287000028
dc.language.isoeng
dc.publisherELSEVIER IRELAND LTD
dc.relation.ispartofATHEROSCLEROSIS
dc.subjectHypertension
dc.subjectC-reactive protein
dc.subjectPolymorphism
dc.subjectHaplotype
dc.subjectTurkish population
dc.subjectCORONARY-HEART-DISEASE
dc.subject3RD NATIONAL-HEALTH
dc.subjectMETABOLIC SYNDROME
dc.subjectRISK-FACTORS
dc.subjectPOLYMORPHISMS
dc.subjectDETERMINANTS
dc.subjectINFLAMMATION
dc.subjectDEFINITION
dc.subjectLONGEVITY
dc.subjectMORTALITY
dc.subjectCardiovascular System & Cardiology
dc.titleAssociation of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar